Search

You searched for "child"

2390 results found

The art of giving generous grains

3 April 2024 | | EYE - General
On the drive home, after a long day of eye screening patients in homeless shelters, I would pass through the boroughs, towns and villages of east London. Stopping at the soup kitchen, I would meet Christian with heavy cataracts, and...

Advanced level practice for ophthalmic nursing

4 December 2025 | | EYE - General
The Royal College of Nursing (RCN) Ophthalmic Nursing Forum (ONF) is committed to clinical excellence through advancing ophthalmic nursing practice and supporting career development. With the increasing demand for ophthalmic services, advanced and specialist practice roles are vital to increase...

Study to slow short-sightedness in young adults

19 December 2025 | research, diagnostics, innovation
The University of Bradford is spearheading a study into the progression of short-sightedness among young adults, aiming to tackle one of the fastest-growing global eye health challenges. The research on short-sightedness, also known as myopia, among people aged in their...

Origami and ophthalmology: precision unfolded

2 February 2024 | | EYE - General
For Eye News Feb/Mar 2024, I was delighted to hear from Dr Hosam Aglan. In New Zealand at the time, Dr Aglan shared wonderful insights into the art of folding origami, along with images from his own creations. The role...

Orbis achieves WHO trachoma elimination threshold in Sheka Zone, Southwest Ethiopia

6 February 2026 | international, charity
Ahead of World Neglected Tropical Diseases (NTD) Day on 30 January, international eye care charity Orbis has announced that it has achieved the World Health Organisation (WHO) threshold for eliminating trachoma as a public health concern in Sheka Zone, Southwest...

Applying for ophthalmology ST1 in 2026: What’s new?

5 December 2025 | | EYE - General
Competition for ophthalmology ST1 has intensified steadily over recent cycles, rising from ~9:1 (2022) to ~10:1 (2023), ~14:1 (2024) and ~22:1 (2025) [1]. Against this background, applicants benefit from a structured approach: mapping achievements to portfolio domains early, identifying gaps...

One bottle, many eyes: The hidden dangers of sharing eyedrops in the community

3 April 2026 | | EYE - Neuro-ophthalmology
We report a case of unilateral mydriasis in a female patient referred by her general practitioner (GP) with a dilated and sluggish left pupil, likely caused by the accidental use of her husband’s prescription eyedrops. This case highlights the importance...

It’s coming home

3 June 2026 |
Yes, this month sees the return of the four-yearly nightmare for me which is the Fifa World Cup. I have had to live with the torture of watching England being knocked out of the tournament ever since I first started...

The restorative prescription: The case for carbon-negative healthcare

1 June 2026 | | sustainability
The Hippocratic Oath begins with a simple, profound directive: ‘First, do no harm.’ Yet, for decades, the global healthcare sector has been locked in a quiet paradox. While doctors work tirelessly to treat illnesses, heat exhaustion and vector-borne diseases, the...

The emotional impact of sight loss: New training from RNIB launched to support eyecare teams

25 June 2026 | charity, training, services
New training to give eyecare professionals all the tools to provide better emotional support to patients receiving a diagnosis of sight loss was rolled out at an event in Westminster this week. The training, developed by RNIB (Royal National Institute...

Eyes on the road – visual standards for car drivers

1 June 2019 | | EYE - General
The author examines the current visual standards required by drivers and asks whether more needs to be done to make roads safer. Are the public adequately protected by the current system of visual standards required by drivers? In a survey...

Acetylcholine receptor antibodies in the diagnosis of ocular myasthenia gravis at the Manchester Royal Eye Hospital

3 August 2023 | | EYE - Neuro-ophthalmology
Myasthenia gravis (MG) is the commonest autoimmune condition to affect the neuromuscular junction. In the UK, its prevalence is 15 per 10,000 [1,2] and recent studies have shown that rates are steadily increasing [3,4]. Aims of this audit The aim...